Vedanta Biosciences is a late clinical-stage biopharmaceutical company developing a new category of microbiome-based oral therapies for gastrointestinal diseases. Vedanta's lead program, VE303, is ...
Intellicheck, Inc. is rated a hold with a 1-year price target of $8.4, reflecting 8% upside and a prudent risk-reward stance.
The Nasdaq correction isn't pausing artificial intelligence (AI) demand -- it's discounting the infrastructure movement ...
Power delivery now spans stacked dies, interposers, bridges, and packages connected by thousands of micro-bumps and TSVs.
Las Vegas, NV - April 08, 2026 - PRESSADVANTAGE - Dr. Andrea Adams-Miller, founder of The RED Carpet Connection, LLC, ...
The plan to address homelessness was announced seven months ago, which includes tiny home communities for seniors, a safe ...
It is late. A caregiver is finally in bed after another day of work, kids, and managing her mother’s medications. The house ...
APT28 deploys PRISMEX using zero-day CVEs since September 2025, targeting Ukraine’s supply chains and NATO partners for ...
Universal Genève is back! ✓ The return of “Le Couturier De La Montre” sees the reboot of the Compax, Polerouter, Cabriolet, ...
This is what’s keeping Hollywood alive right now,” says Pixie USA founder and CEO Jonas Barnes, referring to verticals, or ...
Kansas Gov. Laura Kelly shot down legislation riddled with “bureaucratic red tape,” “political games” and “micro-managing” as ...